Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
1.960
-0.120 (-5.77%)
At close: Mar 9, 2026, 4:00 PM EDT
2.000
+0.040 (2.04%)
After-hours: Mar 9, 2026, 7:55 PM EDT
Moleculin Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 10 | 5 | 29 | 30 | 53 | 50 | |
| Market Cap Growth | 130.21% | -82.21% | -5.48% | -42.91% | 5.47% | 20.43% | |
| Enterprise Value | 3 | -4 | 5 | -20 | -22 | 38 | |
| Last Close Price | 1.96 | 42.50 | 321.90 | 397.50 | 697.50 | 1793.47 | |
| PB Ratio | - | 0.85 | 1.10 | 0.58 | 0.67 | 2.84 | |
| P/TBV Ratio | - | - | 1.92 | 0.74 | 0.78 | 7.62 | |
| Debt / Equity Ratio | -0.01 | 0.08 | 0.02 | 0.01 | 0.00 | 0.02 | |
| Net Debt / Equity Ratio | 0.24 | -0.64 | -0.88 | -0.82 | -0.90 | -0.84 | |
| Net Debt / EBITDA Ratio | 0.26 | 0.14 | 0.78 | 1.40 | 3.10 | 0.76 | |
| Net Debt / FCF Ratio | 0.28 | 0.16 | 0.97 | 1.54 | 3.73 | 0.82 | |
| Quick Ratio | 1.18 | 0.80 | 3.47 | 8.96 | 19.59 | 5.20 | |
| Current Ratio | 1.39 | 0.97 | 3.86 | 9.46 | 20.02 | 5.89 | |
| Return on Equity (ROE) | - | -135.80% | -76.07% | -44.25% | -32.86% | -104.14% | |
| Return on Assets (ROA) | -69.19% | -60.39% | -38.73% | -27.07% | -25.38% | -45.48% | |
| Return on Capital Employed (ROCE) | -165.00% | -230.30% | -94.40% | -58.20% | -28.50% | -75.60% | |
| Earnings Yield | -531.72% | -426.46% | -103.79% | -95.65% | -29.90% | -34.44% | |
| FCF Yield | -232.21% | -467.84% | -82.69% | -91.30% | -35.69% | -36.01% | |
| Buyback Yield / Dilution | -528.05% | -74.28% | -3.60% | -6.43% | -172.97% | -45.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.